T. Rowe Price Associates’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $128M | Sell |
|
|||||
|
2019
Q4 | $463M | Sell |
|
|||||
|
2019
Q3 | $533M | Buy |
|
|||||
|
2019
Q2 | $469M | Buy |
|
|||||
|
2019
Q1 | $342M | Buy |
|
|||||
|
2018
Q4 | $243M | Sell |
|
|||||
|
2018
Q3 | $379M | Sell |
|
|||||
|
2018
Q2 | $387M | Sell |
|
|||||
|
2018
Q1 | $393M | Sell |
|
|||||
|
2017
Q4 | $423M | Sell |
|
|||||
|
2017
Q3 | $835M | Sell |
|
|||||
|
2017
Q2 | $1.33B | Sell |
|
|||||
|
2017
Q1 | $2.06B | Sell |
|
|||||
|
2016
Q4 | $1.95B | Sell |
|
|||||
|
2016
Q3 | $2.93B | Sell |
|
|||||
|
2016
Q2 | $3.83B | Sell |
|
|||||
|
2016
Q1 | $5.65B | Sell |
|
|||||
|
2015
Q4 | $6.78B | Sell |
|
|||||
|
2015
Q3 | $6.12B | Buy |
|
|||||
|
2015
Q2 | $6.57B | Buy |
|
|||||
|
2015
Q1 | $5.89B | Buy |
|
|||||
|
2014
Q4 | $2.74B | Buy |
|
|||||
|
2014
Q3 | $965M | Buy |
|
|||||
|
2014
Q2 | $603M | Buy |
|
|||||
|
2014
Q1 | $529M | Buy |
|
|||||
|
2013
Q4 | $261M | Buy |
|
|||||
|
2013
Q3 | $208M | Buy |
|
|||||
|
2013
Q2 | $83.1M | Buy |
|